G

Genincode PLC
LSE:GENI

Watchlist Manager
Genincode PLC
LSE:GENI
Watchlist
Price: 1.175 GBX -2.08%
Market Cap: £8.8m

Relative Value

GENI price has not been updated for more than 1 year. This may indicate that the stock has been delisted.
GENI doesn't have a meaningful market cap.

The Relative Value of one GENI stock under the Base Case scenario is hidden GBX. Compared to the current market price of 1.175 GBX, Genincode PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GENI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

GENI Competitors Multiples
Genincode PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Genincode PLC
LSE:GENI
8.8m GBP 3 -1.8 -1.4 -1.3
US
CVS Health Corp
NYSE:CVS
96.8B USD 0.2 54.8 14 14
US
Cigna Corp
NYSE:CI
76B USD 0.3 12.4 0 0
US
Cigna Group
XMUN:CGN
63.8B EUR 0.3 12.2 7.8 10
DE
Fresenius SE & Co KGaA
XETRA:FRE
29.2B EUR 1.3 26.3 11 16.6
DE
Fresenius Medical Care AG
XMUN:FME
22.6B EUR 1.2 33.9 10.1 21.6
US
Laboratory Corporation of America Holdings
NYSE:LH
23.2B USD 1.7 26.5 12.7 18.4
US
Quest Diagnostics Inc
NYSE:DGX
22.8B USD 2.1 23.1 12.6 17.1
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.1B EUR 0.6 15.7 6.2 13.3
US
Guardant Health Inc
NASDAQ:GH
12.5B USD 12.8 -30.1 -32.3 -29.4
US
DaVita Inc
NYSE:DVA
10.2B USD 0.7 13.7 7.2 9.8
P/E Multiple
Earnings Growth PEG
UK
G
Genincode PLC
LSE:GENI
Average P/E: 24.3
Negative Multiple: -1.8
N/A N/A
US
CVS Health Corp
NYSE:CVS
54.8
89%
0.6
US
Cigna Corp
NYSE:CI
12.4
38%
0.3
US
C
Cigna Group
XMUN:CGN
12.2
38%
0.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.3
71%
0.4
DE
Fresenius Medical Care AG
XMUN:FME
33.9
37%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
26.5
27%
1
US
Quest Diagnostics Inc
NYSE:DGX
23.1
12%
1.9
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
15.7
37%
0.4
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -30.1 N/A N/A
US
DaVita Inc
NYSE:DVA
13.7
23%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
G
Genincode PLC
LSE:GENI
Average EV/EBITDA: 10.2
Negative Multiple: -1.4
N/A N/A
US
CVS Health Corp
NYSE:CVS
14
28%
0.5
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
7.8
4%
2
DE
Fresenius SE & Co KGaA
XETRA:FRE
11
14%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
10.1
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
12.7
11%
1.2
US
Quest Diagnostics Inc
NYSE:DGX
12.6
N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.2
10%
0.6
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -32.3 N/A N/A
US
DaVita Inc
NYSE:DVA
7.2
5%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
G
Genincode PLC
LSE:GENI
Average EV/EBIT: 15.1
Negative Multiple: -1.3
N/A N/A
US
CVS Health Corp
NYSE:CVS
14
22%
0.6
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
10
5%
2
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.6
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
21.6
25%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
18.4
N/A N/A
US
Quest Diagnostics Inc
NYSE:DGX
17.1
N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.3
25%
0.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -29.4 N/A N/A
US
DaVita Inc
NYSE:DVA
9.8
8%
1.2
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett